ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,246, issued on May 13, was assigned to CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA (Havana).
"Interleukin-15 activity antagonist peptide" was invented by Yunier Rodriguez Alvarez (Artemisa, Cuba), Hilda Elisa Garay Perez (Havana), Osvaldo Reyes Acosta (Havana) and Ania Cabrales Rico (Havana).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses an antagonist peptide of the Interleukin-15 (IL-15) activity, which is characterized in that it comprises an amino acid sequence identified as SEQ ID No. 5 or SEQ ID No. 12, or a homodimer of these peptides, as well as a nucleic acid that encodes for the peptide with the sequence ide...